“…The rationale behind the purported activities of omega 3 fatty acids on the endothelium and vasomotion is manifold. For example, omega 3 fatty acids are anti-inflammatory molecules [ 136 ] and inflammation greatly participates in the development of, e.g., arterial stiffness [ 117 ], impaired vasomotion [ 137 ], and hypertension [ 138 ]. Moreover, that are — paradoxically — anti- rather than pro-oxidant [ 139 , 140 ], via molecular mechanisms that have been largely elucidated and include, e.g., inhibition of NADPH oxidase 4 (Nox 4), V sPLA 2 , and cyclooxygenases, as well as reduced superoxide production [ 140 ], thereby maintaining an adequate “peroxide tone” [ 141 ].…”